Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2016-05-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（刘卫）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by a candidate for an independent director position at Jiangsu Sihuan Bio Co., Ltd. It includes statements about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. The content is focused on the candidate's eligibility and compliance with regulatory requirements for board membership, rather than financial results, management changes, or shareholder voting outcomes. This type of document is typically related to board or management information, specifically announcements or declarations concerning board member candidates. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and content do not suggest it is a full report or an announcement of a report, nor does it fit other categories such as regulatory filings or proxy statements.
2016-05-09 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed qualifications, compliance with regulatory requirements, and declarations about the nominee's independence and eligibility. There is no financial data, no report of financial results, no voting results, no meeting materials, and no mention of any report publication. The content is focused on board/management information, specifically the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 2664 characters, which is relatively short but contains substantive content about management nomination rather than a mere announcement or certification, so it is not RNS or RPA.
2016-05-09 Chinese
2016年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled '江苏四环生物股份有限公司 2016 年第一季度报告全文' which translates to 'Jiangsu Sihuan Biological Co., Ltd. 2016 First Quarter Report Full Text'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2016. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-29 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled '江苏四环生物股份有限公司 2016 年第一季度报告正文' which translates to 'Jiangsu Sihuan Biological Co., Ltd. 2016 First Quarter Report'. It contains detailed financial data for the first quarter of 2016, including income, net profit, cash flow, assets, liabilities, shareholder information, and management statements. The presence of quarterly financial data and analysis indicates this is a comprehensive interim financial report. The document length is 7291 characters, which is sufficient to contain substantive financial data rather than just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-29 Chinese
江苏晨薇生态园科技有限公司了解委估苗木资产市场价值评估报告
Audit Report / Information Classification · 95% confidence The document is a detailed asset valuation report for Jiangsu Chenwei Ecological Park Technology Co., Ltd., specifically assessing the market value of nursery stock assets as of December 31, 2015. It includes a registered asset appraiser's statement, evaluation methods, assumptions, detailed asset listings, and valuation conclusions. The content is a full asset appraisal report, not an announcement or summary. It does not fit categories like Annual Report, Earnings Release, or Regulatory Filings. It is a standalone audit/valuation report focused on asset appraisal, which aligns with the Audit Report / Information (AR) category as it involves applied accounting principles and valuation results but is not a full annual report. The document length and detail confirm it is the report itself, not just an announcement. FY 2015
2016-04-28 Chinese
董事会对带强调事项段无保留意见审计报告的专项说明
Audit Report / Information Classification · 95% confidence The document is an explanation by the board of directors regarding an audit report issued by an accounting firm (立信会计师事务所) for the fiscal year 2015. It specifically discusses the auditor's emphasis of matter paragraph in the unqualified audit opinion, detailing uncertainties related to asset impairment, project termination, and liquidity concerns. The document does not contain the full audit report itself but provides a special explanation about the audit report's emphasis of matter section. The document length is short (1289 characters), and it is an announcement or explanation related to the audit report rather than the audit report itself. According to the classification rules, standalone audit reports or explanations about audit opinions fall under Audit Report / Information (AR). Therefore, this document is best classified as an Audit Report / Information (AR). FY 2015
2016-04-28 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.